Literature DB >> 9433777

Thermodynamics of partitioning of the antimalarial drug mefloquine in phospholipid bilayers and bulk solvents.

M L Go1, T L Ngiam.   

Abstract

The antimalarial drug mefloquine binds avidly to phospholipids in biomembranes. The thermodynamics of the partitioning process in dimyristoylphosphatidylcholine (DMPC) bilayers was investigated to give some insight into the drug-phospholipid interaction. Thermodynamic parameters for the partition equilibria were evaluated from the equilibrium partition coefficients measured as a function of temperature. Negative values of delta H and delta S were obtained for the transfer of mefloquine from the aqueous to the gel phase of the phospholipid. The partitioning is enthalpy controlled which suggests that mefloquine interacts strongly with the phospholipid phase. In contrast, the partitioning of mefloquine into the liquid crystalline phase of DMPC is entropy controlled which is typical of a hydrophobic interaction between mefloquine and the aqueous phase. The partitioning of mefloquine into the bulk solvents octanol and hexane were found to be enthalpy and entropy controlled, respectively. The enthalpy dominated partitioning of mefloquine into gel phase DMPC and octanol is attributed to the occurrence of hydrogen bonding and van der Waals interactions between solute and solvent. The flat shape of mefloquine may further aid its interaction with the orderly domains of the lipidic/organic phase. This is apparent from a comparison of the partitioning characteristics of another structurally related but conformationally different molecule, quinine into DMPC and octanol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9433777     DOI: 10.1248/cpb.45.2055

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  Multicompartimental nanoparticles for co-encapsulation and multimodal drug delivery to tumor cells and neovasculature.

Authors:  Lívia Palmerston Mendes; Marilisa Pedroso Nogueira Gaeti; Paulo Henrique Marcelino de Ávila; Marcelo de Sousa Vieira; Bruna Dos Santos Rodrigues; Renato Ivan de Ávila Marcelino; Lílian Cristina Rosa Dos Santos; Marize Campos Valadares; Eliana Martins Lima
Journal:  Pharm Res       Date:  2013-10-30       Impact factor: 4.200

2.  Dehydration-induced redistribution of amphiphilic molecules between cytoplasm and lipids is associated with desiccation tolerance in seeds.

Authors:  J Buitink; O Leprince; F A Hoekstra
Journal:  Plant Physiol       Date:  2000-11       Impact factor: 8.340

3.  Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin.

Authors:  D Caridha; D Yourick; M Cabezas; L Wolf; T H Hudson; G S Dow
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

4.  Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols.

Authors:  Erin Milner; William McCalmont; Jayendra Bhonsle; Diana Caridha; Jose Cobar; Sean Gardner; Lucia Gerena; Duane Goodine; Charlotte Lanteri; Victor Melendez; Norma Roncal; Jason Sousa; Peter Wipf; Geoffrey Stuart Dow
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

5.  Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice.

Authors:  Geoffrey S Dow; Erin Milner; Ian Bathurst; Jayendra Bhonsle; Diana Caridha; Sean Gardner; Lucia Gerena; Michael Kozar; Charlotte Lanteri; Anne Mannila; William McCalmont; Jay Moon; Kevin D Read; Suzanne Norval; Norma Roncal; David M Shackleford; Jason Sousa; Jessica Steuten; Karen L White; Qiang Zeng; Susan A Charman
Journal:  Malar J       Date:  2011-06-06       Impact factor: 2.979

6.  Thermodynamics of selective serotonin reuptake inhibitors partitioning into 1,2-dioleoyl-sn-glycero-3-phosphocholine bilayers.

Authors:  Dat T N Ngo; Trinh Q Nguyen; Hieu K Huynh; Trang T Nguyen
Journal:  RSC Adv       Date:  2020-10-27       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.